Europe Typhoid Fever Vaccines Market to Grow at a CAGR of 9.0% to reach US$ 145.36 Million from 2020 to 2027

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Typhoid Fever Vaccines Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Typhoid Fever Vaccines Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Rising Incidence and Mortality of Typhoid Accelerate Demand for Typhoid Conjugate Vaccines

5.2 Market Opportunities

5.2.1 Combination Vaccines

5.3 Future Trends

5.3.1 Government Support for the Typhoid Immunization to Favor Market

5.4 Impact of Drivers and Restraints

6. Europe Typhoid Fever Vaccines Market Regional Analysis

6.1 Europe Typhoid Fever Vaccines Market Overview

6.2 Europe Typhoid Fever Vaccines Market Revenue 2017-2027 (US$ Million)

6.3 Europe Typhoid Fever Vaccines Market Forecast Analysis

7. Europe Typhoid Fever Vaccines Market Analysis – by Vaccine Type

7.1 Live Attenuated Vaccine

7.1.1 Overview
7.1.2 Live Attenuated Vaccine: Europe Typhoid Fever Vaccines Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Capsular Polysaccharide Vaccines

7.2.1 Overview
7.2.2 Capsular Polysaccharide Vaccines: Europe Typhoid Fever Vaccines Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Conjugate Vaccine

7.3.1 Overview
7.3.2 Conjugate Vaccine: Europe Typhoid Fever Vaccines Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Typhoid Fever Vaccines Market Analysis – by Route of administration

8.1 Oral and Injectable

8.1.1 Overview
8.1.2 Oral and Injectable: Europe Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

9. Europe Typhoid Fever Vaccines Market – Europe Analysis

9.1 Europe

9.1.1 Europe Typhoid Fever Vaccines Market Breakdown, by Key Country, 2020 and 2027 (%)
9.1.1.1 Europe Typhoid Fever Vaccines Market – Revenue and Forecast Analysis – by Country
9.1.1.1 UK: Europe Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

9.1.1.1.1 UK: Europe Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
9.1.1.1.2 UK: Europe Typhoid Fever Vaccines Market Breakdown, by Route of administration

9.1.1.2 Germany: Europe Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

9.1.1.2.1 Germany: Europe Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
9.1.1.2.2 Germany: Europe Typhoid Fever Vaccines Market Breakdown, by Route of administration

9.1.1.3 France: Europe Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

9.1.1.3.1 France: Europe Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
9.1.1.3.2 France: Europe Typhoid Fever Vaccines Market Breakdown, by Route of administration

9.1.1.4 Russia: Europe Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

9.1.1.4.1 Russia: Europe Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
9.1.1.4.2 Russia: Europe Typhoid Fever Vaccines Market Breakdown, by Route of administration

9.1.1.5 Italy: Europe Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

9.1.1.5.1 Italy: Europe Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
9.1.1.5.2 Italy: Europe Typhoid Fever Vaccines Market Breakdown, by Route of administration

9.1.1.6 Rest of Europe: Europe Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

9.1.1.6.1 Rest of Europe: Europe Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
9.1.1.6.2 Rest of Europe: Europe Typhoid Fever Vaccines Market Breakdown, by Route of administration

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Europe Typhoid Fever Vaccines Market Industry Landscape

11.1 Overview

11.2 Mergers and Acquisitions

11.3 Agreements, Collaborations, and Joint Ventures

11.4 New Product Launches

11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 Sanofi

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 GlaxoSmithKline plc

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 Paxvax Inc

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 Prokarium Ltd

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 Scandinavian Biopharma

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

13. Appendix

13.1 About Business Market Insights